Your browser doesn't support javascript.
loading
Correction to: Regional differences in baseline disease activity and remission rates following golimumab treatment for RA: results from the GO-MORE trial.
Durez, Patrick; Pavelka, Karel; Lazaro, Maria Alicia; Garcia-Kutzbach, Abraham; Moots, Robert J; Amital, Howard; Govoni, Marinella; Vastesaeger, Nathan.
Afiliação
  • Durez P; Pôle de Recherche en Rhumatologie, Institut de Recherche Expérimentale et Clinique, UCL Saint-Luc, DurezAvenue Hippocrate 10, B-1200, Brussels, Belgium. patrick.durez@uclouvain.be.
  • Pavelka K; Institute of Rheumatology (Revmatologicky Ustav), Na Slupi 4, 128 50, Praha 2, Czech Republic.
  • Lazaro MA; Instituto de Rehabilitacion Psicofisica de la Ciudad de Buenos Aires, Echeverria 955, C1428DQG, Buenos Aires, Argentina.
  • Garcia-Kutzbach A; AGAR, UFM, 6 Avenida 7-55, zona 10, 01010, Guatemala City, Guatemala.
  • Moots RJ; University Hospital Aintree, Longmoor Ln, Liverpool, L9 7AL, UK.
  • Amital H; Sheba Medical Center-Tel-Hashomer, Emek HaEla St 1, Ramat Gan, Israel.
  • Govoni M; MSD, Via Vitorchiano, 151, 00189, Rome, RM, Italy.
  • Vastesaeger N; MSD, Clos du Lynx 5, 1200, Woluwe-Saint-Lambert, Belgium.
Clin Rheumatol ; 37(7): 2017-2018, 2018 07.
Article em En | MEDLINE | ID: mdl-29752584
ABSTRACT
The original publication contains two areas which require correcting. None of these errors change the results or conclusions of the article, but the authors wish to highlight the areas of change to the reader.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article